Otology | Evidence-Based Management of Sudden hearing loss
By
Dr. (Prof) Sujana S.Chandrasekhar
Partner, ENT & Allergy Associates,
Past President, AAOHNS,
Clinical Faculty, Zucker & Icahn Schools of Medicine,
New York, USA
Guy's and St Thomas Virtual Grand Round
14th April 2021
00:40 - Definition and burden of SSNHL
03:16 - 'Idiopathic' SSNHL - viral/autoimmune?
10:50 - Statement 1: exclude conductive loss
12:15 - Timeline of presentations
14:35 - Statement 2: modifying factors
15:24 - Statement 3: CT scans
16:45 - Statement 4: Audiometric confirmation within 14 days
23:36 - Statement 5: Laboratory testing
27:16 - Covid vaccine and SSNHL
28:33 - Statement 6: Retrocochlear pathology
31:20 - Statement 7: patient education
32:24 - Statement 8 - initial corticosteroids
35:09 - Statement 9 - Hyperbaric oxygen therapy
35:46 - Statement 10: Intratympanic corticosteroids
46:07 - Statement 11: Other pharmacological therapy
47:05 - Statement 12: Outcomes assessment
48:55 - Statement 13: Rehabilitation
50:22 - Implants for unrecovered SSNHL
50:51 - Current research